The therapeutic potential of atorvastatin in treatment of <i>G. lamblia</i> infected mice; <i>in silico</i>, parasitological, and histopathological study. [PDF]
Mohamed K +8 more
europepmc +1 more source
Cost-Utility Analysis of High-Intensity Statins; Atorvastatin 40 and 80 mg versus Rosuvastatin 20 mg from Egyptian Public Payer's Perspective: A Markov Model. [PDF]
Ibrahim A +4 more
europepmc +1 more source
Drug-Drug Interaction of Chiglitazar with Empagliflozin, Atorvastatin, and Valsartan: An Open-Label, Single-Center, Self-Control, 3-Period Study. [PDF]
Sheng L, Li X, Yu J, Yang X, Li H, Xu H.
europepmc +1 more source
Atorvastatin Attenuates Human Cardiac Fibroblast Activation, with Associated Changes in GATA4/MEF2C and Selected Fibrosis-Related microRNAs. [PDF]
Chomaničová N +5 more
europepmc +1 more source
Atorvastatin and almonertinib-induced myopathy in a polypharmacy context: a case report. [PDF]
Zhou J, Yu L, Xu H.
europepmc +1 more source
[Retracted] Atorvastatin increases lipopolysaccharide-induced expression of tumour necrosis factor-α-induced protein 8-like 2 in RAW264.7 cells. [PDF]
Liu MW, Su MX, Zhang W, Wang L, Qian CY.
europepmc +1 more source
The Effect of Liraglutide on the Hypolipidemic, Anti-Inflammatory, and Antioxidant Properties of Atorvastatin Mediated via the Nrf2/HO-1 Signaling Pathway: In Vivo and In Silico Validation. [PDF]
Kamar SA +11 more
europepmc +1 more source
Effect of Atorvastatin Combined With Herb-Partitioned Moxibustion on PON-1 in Patients With Atherosclerotic Cerebral Infarction: A Randomized Controlled Trial. [PDF]
An W +9 more
europepmc +1 more source
A Comprehensive, Updated Review of Ezetimibe: Evidence-Based Clinical Use for Atherosclerotic Cardiovascular Disease. [PDF]
Liu HH, Liu ZH, Chen SS, Zhu CG, Li JJ.
europepmc +1 more source
High-throughput signal detection of hepatotoxic drug-drug interactions in hospitalized elderly patients: an NLP-driven pharmacovigilance study. [PDF]
Ma J, Chen H, Guo C, He G, Yang G.
europepmc +1 more source

